Sentinel Lymph Node Biopsies &
Who Should Have Them
Making Progress in
Heated Intraperitoneal Chemotherapy (HIPEC)
for Metastatic Gynecologic Cancer
Managing Triple-Negative &
Hereditary Breast Cancer
Melinda L. Telli, MD
Associate Professor, Medicine
Director, Breast Cancer Program, Stanford Cancer Institute
Dr. Melinda L. Telli leads the Breast Cancer Program and specializes in the treatment of triple-negative and hereditary breast cancers. Her research focuses on the validation of homologous recombination deficiency biomarkers to identify patients with sporadic triple-negative breast cancer and the development of PARP inhibitor therapy for BRCA1 and BRCA2 mutation-associated cancers.
Oliver Dorigo, MD, PhD
Associate Professor, Obstetrics & Gynecology
Director, Gynecologic Cancer Program, Stanford Cancer Institute
Dr. Oliver Dorigo leads the Gynecologic Cancer Program and specializes in the treatment of ovarian, cervical, endometrial, vaginal, and vulvar cancers. He is dedicated to the expansion of the clinical trials program and the development of novel therapies for ovarian cancer in the laboratory. In his surgical practice, Dr. Dorigo emphasizes use of minimally invasive technologies.
Kimberly Sue Stone, MD
Clinical Assistant Professor, Surgery
Director, Stanford Medicine Network Breast Oncology Program
Dr. Kimberly Sue Stone specializes in breast surgical oncology and treats all conditions related to breast health. She is skilled in total skin and nipple sparing mastectomy, wireless lumpectomy, benign breast disease excisions, axillary surgery, sentinel lymph node biopsy, and lymph node dissection. Dr. Stone believes patient empowerment and education are at the heart of excellent care.
Amer Karam, MD
Clinical Professor, Obstetrics & Gynecology
Dr. Amer Karam specializes in the treatment of gynecologic cancers, including cervical, vaginal, vulvar, ovarian, fallopian tube, and peritoneal cancer. He is also a leader in HIPEC treatment, an innovative treatment that delivers high dose chemotherapy directly to the site of tumor during surgery. Dr. Karam has a strong interest in minimally invasive and robotic surgery.
The Stanford Women’s Cancer Center has clinics in Emeryville, Palo Alto, Pleasanton, San Jose, and Turlock. The Breast Cancer Program and the Gynecologic Cancer Program provide specialized expertise in treating every stage and subtype of breast and gynecologic cancers and are affiliate with the Stanford Cancer Institute, an NCI-Designated Comprehensive Cancer Center.